Global Alliance Finds Genetic Cause of Neurological Disease
The recognition of a previously unidentified genetic cause of late-onset cerebellar ataxia is reported in a new study that was...
The recognition of a previously unidentified genetic cause of late-onset cerebellar ataxia is reported in a new study that was...
Antibiotic usage is crucial in the treatment of many bacterial infections. However, the quantity of bacteria strains that are impervious...
Data shown at the 64th American Society of Haematology (ASH) conference in New Orleans demonstrates that elranatamab is effective and...
The generic version of the COVID-19 oral antiviral therapy candidate nirmatrelvir has been approved by the World Health Organization Prequalification...
Researchers in Singapore have identified a brand-new therapeutic target called ADAM10 that may be used to treat people who have...
An Italian study that was recently published in Neurology, the official journal of the American Academy of Neurology, suggests that...
Multiple provisions crucial to FDA operations and authority, in addition to clinical research sponsors and pharmaceutical manufacturers, are included in...
The benefits of earlier detection and quicker access to treatments will be felt by cancer patients as well as newborns...
The first gene therapy for non-muscle invasive bladder cancer (NMIBC) in individuals with high-risk carcinoma in situ (CIS) with or...
The agency that suggests which medications should be allowed in Europe has backed five new ones, including a gene therapy...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.